{"name":"Michael Morse, MD","slug":"michael-morse-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5SYzhDNzBtQ19UdkFBbXhvRTdYanRKakhvNWdrVHQwc2FDZC1uQ0U4ZGtXTGJkR05DVzhNODlYSktBVldiemJqaS1vc3drTTFQVFpPenBwaS1HeGFpNDcwYkNJcGwzU0ZKcnBOaW94Rmw1OGU2NVF6dk9sOA?oc=5","date":"2022-10-19","type":"pipeline","source":"Wiley","summary":"Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians - Wiley","headline":"Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4tMm9SZEctM09LSE5lcGFlT1Q2VDFzYXFBTDEySjEyQ3Y5SGJvTldVRjA5QVduTl9nc3RSYXBPSHdpSEFJcUxXTEhlV2RjVGtuT2JtWERlSm93Z0pyWm1Z?oc=5","date":"2018-04-30","type":"pipeline","source":"NEJM","summary":"Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose - NEJM","headline":"Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}